STAT

Opinion: 30 years is too long to wait for new medicines. There are ways to speed up drug development

In the 1990s, gene therapy wasn't mature enough to turn the millions invested in it into a product. Let's not keep making the same mistake.
___ Source: General Photographic Agency/Getty Images

Have you heard the oft-repeated “fact” that it takes at least 10 years from initial discovery for a new drug to enter the marketplace? Take it with a grain of salt. The drug development journey is closer to 30 years.

I’ve experienced the lag time between discovery and commercial success as the co-founder of a biotech startup, and now I study it at the Center for Integration of Science and Industry at Bentley University.

In the early 1990s, I co-founded GeneMedicine Inc., one of the first

You're reading a preview, sign up to read more.

More from STAT

STAT6 min readSociety
A Drug Maker Courted Controversy When It Shut Out A Family-run Rival. Now Some Patients Say The Medicine Isn’t Working
After the FDA approved a more expensive drug for a rare neuromuscular disorder, some patients say they want to go back to an older, cheaper version.
STAT6 min read
Opinion: Working With ICER, Or Around It, On Cost-effectiveness Estimates
Those hoping to get a reasonable outcome from an ICER value assessment must approach the process with a sophisticated strategy.
STAT7 min read
In France, It’s Illegal For Consumers To Order A DNA Spit Kit. Activists Are Fighting Over Lifting The Ban
Under French law, having a direct-to-consumer genetic test can, technically speaking, put you at risk of being fined about $4,140.